VALIDATION IMAGES
Lane 1: Hela Cells; Lane 2: Mouse Placenta; Lane 3: MCF-7 Cells; Probed with H2AFY (6C8) Monoclonal Antibody (bsm-54167R) at 1:500 overnight at 4°C followed by a conjugated secondary antibody for 60 minutes at 37°C.
IF(ICC) staining with H2AFY (6C8) Monoclonal Antibody (bsm-54167R) at 1:100 in Hela cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
IF(ICC) staining with H2AFY (6C8) Monoclonal Antibody (bsm-54167R) at 1:100 in HepG2 cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
IF(ICC) staining with H2AFY (6C8) Monoclonal Antibody (bsm-54167R) at 1:100 in PC-3M cells (green). The nuclear counterstain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.
Paraformaldehyde-fixed and paraffin-embedded Human Lung Cancer tissue incubated with H2AFY (6C8) Monoclonal Antibody (bsm-54167R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human Thyroid tissue incubated with H2AFY (6C8) Monoclonal Antibody (bsm-54167R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human Placenta tissue incubated with H2AFY (6C8) Monoclonal Antibody (bsm-54167R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Mouse Fallopian Tube tissue incubated with H2AFY (6C8) Monoclonal Antibody (bsm-54167R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.